ProQR Therapeutics (PRQR) Other Operating Expenses (2014 - 2026)
ProQR Therapeutics (PRQR) posted quarterly Other Operating Expenses of -$0.0 for Q1 2026, down 100.0% on a QoQ basis from -$0.0 in Q2 2023.
ProQR Therapeutics (PRQR) Other Operating Expenses (2014 - 2026) Analysis & Trends
ProQR Therapeutics (PRQR) has reported Other Operating Expenses for 9 consecutive years, with -$0.0 the latest figure, recorded in Q1 2026.
- Quarterly Other Operating Expenses changed N/A year-over-year to -$0.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$0.0 (changed N/A YoY) and the FY2025 annual result came in at $0.0, changed N/A from the prior year.
- Other Operating Expenses declined to -$0.0 in Q1 2026 per PRQR's latest filing, from -$0.0 in the prior quarter.
- Over the last five years, Other Operating Expenses for PRQR reached as high as -$0.0 in Q2 2023 and fell as low as -$0.0 in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | ProQR Therapeutics | 219.53 Mn | 175.72 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.00 |
| Jun 30, 2023 | 0.00 |
| Jun 30, 2021 | 0.00 |
| Dec 31, 2020 | 0.00 |
| Mar 31, 2020 | 0.00 |
| Jun 30, 2019 | 0.00 |
| Jun 30, 2017 | 0.00 |
| Mar 31, 2017 | 0.00 |
| Dec 31, 2016 | 0.00 |
| Sep 30, 2016 | 0.00 |
| Dec 31, 2015 | 0.00 |
| Mar 31, 2015 | -33.69 Bn |
| Dec 31, 2014 | 0.00 |
| Sep 30, 2014 | 0.00 |
| Jun 30, 2014 | 0.00 |
| Mar 31, 2014 | -8.82 Bn |